Baxter Says Generic Co. Infringed Hypertension Med Patent
Baxter International Inc. on Tuesday hit HQ Specialty Pharma Corp. with a lawsuit in New Jersey federal court alleging HQ's proposed generic version of its blood pressure and heart rhythm disorder...To view the full article, register now.
Already a subscriber? Click here to view full article